URMC-099 prophylaxis prevents hippocampal vascular vulnerability and synaptic damage in an orthopedic model of delirium superimposed on dementia

Systemic perturbations can drive a neuroimmune cascade after surgical trauma, including affecting the blood-brain barrier (BBB), activating microglia, and contributing to cognitive deficits such as delirium. Delirium superimposed on dementia (DSD) is a particularly debilitating complication that renders the brain further vulnerable to neuroinflammation and neurodegeneration, albeit these molecular mechanisms remain poorly understood. Here, we have used an orthopedic model of tibial fracture/fixation in APPSwDI/mNos2(-/-) AD (CVN-AD) mice to investigate relevant pathogenetic mechanisms underlying DSD. We conducted the present study in 6-month-old CVN-AD mice, an age at which we speculated amyloid-beta pathology had not saturated BBB and neuroimmune functioning. We found that URMC-099, our brain-penetrant anti-inflammatory neuroprotective drug, prevented inflammatory endothelial activation, breakdown of the BBB, synapse loss, and microglial activation in our DSD model. Taken together, our data link post-surgical endothelial activation, microglial MafB immunoreactivity, and synapse loss as key substrates for DSD, all of which can be prevented by URMC-099.

Automated summary

Systemic perturbations following surgical trauma can lead to a neuroimmune cascade, affecting the blood-brain barrier, activating microglia, and contributing to cognitive deficits such as delirium. Delirium superimposed on dementia is a severe complication that increases the vulnerability of the brain to neuroinflammation and neurodegeneration, with molecular mechanisms not yet fully understood. In this study, using a mouse model, the researchers found that the brain-penetrant anti-inflammatory neuroprotective drug URMC-099 could prevent inflammatory endothelial activation, breakdown of the blood-brain barrier, synapse loss, and microglial activation in the delirium superimposed on dementia model.